动物咀嚼片市场－全球产业规模、份额、趋势、机会及预测（按类型、药物、通路、地区及竞争格局划分，2021-2031年）

全球兽用咀嚼片市场预计将从 2025 年的 1.5 亿美元成长到 2031 年的 2.3 亿美元，复合年增长率为 7.38%。

这些产品是偏好的口服给药系统，旨在透过咀嚼的方式餵食宠物、补充营养或进行牙齿护理。市场成长的主要驱动力是宠物饲主对宠物的日益人性化以及他们在预防保健和高端健康产品上的支出增加。此外，慢性兽医疾病的增加也推动了对易于给药、确保宠物和饲主都能轻鬆遵从的治疗方法的需求。这些因素预示着宠物保健正在发生永久性的变革，而非昙花一现的趋势。

阻碍市场发展的主要障碍之一是复杂的法规环境，尤其是在安全性和有效性声明方面，各国监管标准差异显着。由于需要进行严格的测试来证明新配方的稳定性和口感，企业常常面临代价高昂的延误。根据美国宠物用品协会 (APPA) 预测，到 2024 年，一半的狗主饲主大约三分之一的猫饲主会给他们的宠物服用营养补充剂或维生素。如此高的使用率凸显了消费者对便捷服用方式的强烈需求，但严格的合规标准仍阻碍新型咀嚼片产品快速进入全球市场。

市场驱动因素

宠物人性化和优质化的趋势日益明显，饲主将宠物视为家庭成员，并努力为其提供最高标准的医疗保健，这正在改变全球动物咀嚼片市场。这种情感纽带推动了消费者对高端健康产品的大量支出，并促使他们的偏好从基本食品转向更先进、偏好的药物和营养补充剂输送系统。根据美国宠物产品协会 (APPA) 于 2025 年 3 月发布的《2025 年产业趋势报告》，美国宠物产业的支出将在 2024 年达到 1,520 亿美元，这表明饲主已准备好在动物福利方面进行大量投资。在不断增长的宠物拥有率（包括澳洲动物医学协会 2025 年 9 月发布的《澳洲宠物》报告中指出的 73% 的家庭宠物普及率）的支持下，这些趋势正在推动高端咀嚼片的研发，其品质可与人类营养补充剂相媲美。

第二个关键驱动因素是功能性和营养补充剂需求的增长，这使得咀嚼片成为预防保健的首选形式。随着宠物饲主将可持续的健康维护置于被动治疗之上，用于缓解焦虑、改善关节活动度和维护牙齿健康的口腔产品的消费量显着增加。软性咀嚼片的偏好和易用性使其比标准片剂更能有效地维持日常护理。这种转变也反映在财务表现上。维克公司于2025年1月发布的「2024年第四季合併销售报告」显示，经外汇调整后，其伴侣动物部门的销售额增长了10.7%，这主要得益于其牙科产品线和特种产品的强劲增长。为了应对这一趋势，製造商正在开发采用疾病特异性配方和天然成分的产品，以抢占不断扩大的预防性护理市场。

市场挑战

复杂的成分安全性和功效声明监管框架对全球兽用咀嚼片市场的发展构成重大障碍。生产商必须遵守不同的区域标准，这些标准通常要求针对特定市场采用独特的配方和额外的测试通讯协定。与传统片剂不同，咀嚼片必须经过严格的稳定性和偏好检验，以确保活性成分即使与香料混合也能保持效力。这种全球统一性的缺失显着增加了研发所需的资金和时间，迫使企业将过多资源用于合规而非创造性。

这种监管瓶颈限制了新产品的上市速度，阻碍了市场充分利用对便利用药剂型日益增长的需求。根据欧洲动物健康协会（AnimalhealthEurope）的数据，欧洲药品管理局（EMA）在2024年仅核准了25种新的动物用药品。欧盟范围内如此少的核准数量凸显了製造商在将符合规定的创新产品推向市场方面面临的巨大挑战。因此，沉重的合规负担成为限制市场成长的障碍，并减缓了新型咀嚼片疗法在消费者中的广泛应用。

市场趋势

多功能复合咀嚼片的兴起正成为宠物饲主的一大趋势，他们希望将复杂的营养补充方案简化为单一、易用的剂型。随着功能性产品需求的成长，消费者正逐渐抛弃多种单一成分的产品，转而选择能够同时支持免疫功能、肠道健康和关节健康的「全效合一」软性咀嚼片。这种转变的驱动力源于家庭对成本效益的追求以及减少宠物「服药疲劳」的需求，迫使製造商开发更具相容性的活性成分配方。 2025年4月发布的GlobalPETS报告《Zesty Paws品牌所有者揭示宠物营养与照护是主要收入来源》印证了这项转变的商业性可行性。报告指出，Zesty Paws品牌预计在2024财年实现11.8%的收入成长，这主要得益于其多功能软咀嚼片产品线的成功。

同时，对可生物降解和永续包装的关注正迅速成为关键的竞争因素。随着环保意识日益增强的消费者越来越关註一次性塑胶袋对环境的影响，这一趋势正在从根本上改变宠物咀嚼包装和供应链。企业被迫从传统的金属化聚酯薄膜转向消费后回收和可堆肥材料，同时也要维持对产品稳定性至关重要的防潮性能。消费者的偏好凸显了这项转变的迫切性。根据DC Pet Distribution于2025年5月发布的《2025年宠物产业永续包装趋势》报告，约70%的美国宠物饲主现在更倾向于选择那些透过可堆肥或可回收包装来展现其永续性承诺的品牌。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球动物咀嚼片市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依成分类型（植物来源合成、化学合成）
  • 透过药物治疗（止痛药、抗感染剂、抗溃疡药、矿物质、维生素）
  • 按分销管道（线上兽医诊所商店、兽医诊所、兽药店）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美动物咀嚼片市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲动物咀嚼片市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区动物咀嚼片市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲动物咀嚼片市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲动物咀嚼片市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球动物咀嚼片市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Allaccem Inc
• Bayer AG
• Boehringer Ingelheim GmbH
• Ceva Animal Health LLC
• Colgate-Palmolive Co
• Merck & Co., Inc.
• Nestle SA
• Zoetis Inc
• Dechra Veterinary Products Ltd
• Elanco Animal Health Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Animal Chewables Market is projected to expand from USD 0.15 Billion in 2025 to USD 0.23 Billion by 2031, reflecting a compound annual growth rate of 7.38%. These products function as tasty oral delivery systems designed to administer pharmaceuticals, nutraceuticals, or dental care through the act of chewing. The market's upward trajectory is largely fueled by the growing humanization of pets, encouraging owners to spend on preventative care and high-end wellness items. Additionally, the increase in chronic veterinary issues drives the need for easy-to-administer treatments that ensure adherence without stressing the pet or the handler. These factors mark a permanent evolution in pet health management rather than serving as distinct, temporary fads.

One major hurdle slowing market progress is the complicated regulatory environment concerning safety and efficacy claims, which differs widely across international borders. Companies often encounter expensive delays due to the strict testing needed to prove the stability and taste of new formulas. According to the American Pet Products Association, in 2024, half of all dog owners and nearly one-third of cat owners gave supplements or vitamins to their pets. This significant usage highlights the strong consumer appetite for user-friendly delivery methods, though rigorous compliance standards continue to obstruct the swift introduction of new chewable products to the global stage.

Market Driver

The trends of rising pet humanization and premiumization are transforming the global animal chewables sector, as owners increasingly treat their pets like family members worthy of top-tier healthcare. This emotional connection prompts significant spending on luxury wellness items, moving consumer choices away from basic food toward advanced, palatable delivery systems for medications and supplements. Data from the American Pet Products Association's '2025 State of the Industry Report' in March 2025 indicates that U.S. pet industry spending hit $152 billion in 2024, demonstrating owners' readiness to invest heavily in animal welfare. Supported by rising ownership rates-such as the 73% household penetration noted in Animal Medicines Australia's September 2025 'Pets in Australia' report-these patterns encourage the creation of premium chewable products that rival human nutraceutical standards.

A second pivotal driver is the escalating demand for functional and nutritional supplements, which has established chewables as the favored format for preventative care. As pet parents prioritize enduring wellness over reactive treatments, consumption of oral products for anxiety, joint mobility, and dental health has risen markedly. The palatability and ease of soft chews make them more effective than standard tablets for maintaining daily routines. This shift is reflected in financial results; Virbac's '2024 fourth quarter consolidated sales' report from January 2025 highlights a 10.7% revenue jump in their companion animal division at constant exchange rates, bolstered by dental ranges and specialty items. In response, manufacturers are innovating with condition-specific formulas and natural ingredients to seize this growing preventative market.

Market Challenge

The intricate regulatory framework governing ingredient safety and efficacy claims acts as a major obstacle to the Global Animal Chewables Market's development. Producers must maneuver through varying standards across different regions, frequently requiring unique formulations or supplementary testing protocols for specific markets. Unlike conventional tablets, chewables demand strict verification of stability and palatability to guarantee that active pharmaceutical ingredients remain potent when combined with flavoring agents. This lack of global harmonization substantially inflates the capital and time needed for research and development, compelling firms to divert excessive resources toward compliance rather than creative innovation.

This regulatory bottleneck restricts the frequency of new product introductions, hindering the market from fully exploiting the growing demand for user-friendly medication forms. Data from AnimalhealthEurope indicates that in 2024, the European Medicines Agency authorized just 25 new animal health products for use. This modest approval volume across the European Union highlights the immense challenges manufacturers encounter in commercializing compliant innovations. Consequently, the heavy burden of compliance functions as a barrier that limits market growth and delays the availability of novel chewable treatments for consumers.

Market Trends

The rise of multifunctional combination chews is becoming a leading trend as pet owners look to streamline complex supplement schedules into single, easy-to-use dosage forms. While demand for functional products grows, consumers are shifting away from multiple single-ingredient items in favor of "all-in-one" soft chews that simultaneously target immune function, gut health, and joint support. This transition is driven by a wish to improve household cost-efficiency and minimize "pill fatigue" for the animal, pushing manufacturers to develop active ingredient matrices that are highly compatible. The commercial viability of this shift is confirmed by the April 2025 GlobalPETS report, 'Zesty Paws owner reveals pet nutrition and care as key revenue contributors,' which notes that the Zesty Paws brand realized an 11.8% revenue increase in fiscal year 2024, largely fueled by the success of their multifunctional soft chew lines.

Concurrently, a focus on biodegradable and sustainable packaging is fast becoming a crucial competitive factor as eco-aware consumers increasingly scrutinize the environmental footprint of single-use plastic pouches. This trend fundamentally changes the presentation and supply chain of chewables, compelling companies to switch from conventional metallized polyester films to post-consumer recycled or compostable materials, all while maintaining the moisture barrier essential for product stability. The urgency of this shift is highlighted by consumer preferences; the DC Pet Distribution 'Sustainable Packaging Trends in the 2025 Pet Industry' report from May 2025 indicates that nearly 70% of U.S. pet owners now prefer brands that show a commitment to sustainability through compostable or recyclable packaging options.

Key Market Players

• Allaccem Inc
• Bayer AG
• Boehringer Ingelheim GmbH
• Ceva Animal Health LLC
• Colgate-Palmolive Co
• Merck & Co., Inc.
• Nestle SA
• Zoetis Inc
• Dechra Veterinary Products Ltd
• Elanco Animal Health Inc

Report Scope

In this report, the Global Animal Chewables Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Chewables Market, By Composition Type

• Botanically Synthesized
• Chemically Synthesized

Animal Chewables Market, By Drug

• Analgesics
• Anti-Infective
• Anti-Ulcers
• Minerals
• Vitamins

Animal Chewables Market, By Distribution Channel

• Online Veterinary Stores
• Veterinary Clinics
• Veterinary Pharmacies

Animal Chewables Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Chewables Market.

Available Customizations:

Global Animal Chewables Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Chewables Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Composition Type (Botanically Synthesized, Chemically Synthesized)
  • 5.2.2. By Drug (Analgesics, Anti-Infective, Anti-Ulcers, Minerals, Vitamins)
  • 5.2.3. By Distribution Channel (Online Veterinary Stores, Veterinary Clinics, Veterinary Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Animal Chewables Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Composition Type
  • 6.2.2. By Drug
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Chewables Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Composition Type
      • 6.3.1.2.2. By Drug
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Animal Chewables Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Composition Type
      • 6.3.2.2.2. By Drug
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Animal Chewables Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Composition Type
      • 6.3.3.2.2. By Drug
      • 6.3.3.2.3. By Distribution Channel

7. Europe Animal Chewables Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Composition Type
  • 7.2.2. By Drug
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Chewables Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Composition Type
      • 7.3.1.2.2. By Drug
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Animal Chewables Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Composition Type
      • 7.3.2.2.2. By Drug
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Animal Chewables Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Composition Type
      • 7.3.3.2.2. By Drug
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Animal Chewables Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Composition Type
      • 7.3.4.2.2. By Drug
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Animal Chewables Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Composition Type
      • 7.3.5.2.2. By Drug
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Animal Chewables Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Composition Type
  • 8.2.2. By Drug
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Animal Chewables Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Composition Type
      • 8.3.1.2.2. By Drug
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Animal Chewables Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Composition Type
      • 8.3.2.2.2. By Drug
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Animal Chewables Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Composition Type
      • 8.3.3.2.2. By Drug
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Animal Chewables Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Composition Type
      • 8.3.4.2.2. By Drug
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Animal Chewables Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Composition Type
      • 8.3.5.2.2. By Drug
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Animal Chewables Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Composition Type
  • 9.2.2. By Drug
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Animal Chewables Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Composition Type
      • 9.3.1.2.2. By Drug
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Animal Chewables Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Composition Type
      • 9.3.2.2.2. By Drug
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Animal Chewables Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Composition Type
      • 9.3.3.2.2. By Drug
      • 9.3.3.2.3. By Distribution Channel

10. South America Animal Chewables Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Composition Type
  • 10.2.2. By Drug
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Animal Chewables Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Composition Type
      • 10.3.1.2.2. By Drug
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Animal Chewables Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Composition Type
      • 10.3.2.2.2. By Drug
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Animal Chewables Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Composition Type
      • 10.3.3.2.2. By Drug
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Animal Chewables Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Allaccem Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bayer AG
• 15.3. Boehringer Ingelheim GmbH
• 15.4. Ceva Animal Health LLC
• 15.5. Colgate-Palmolive Co
• 15.6. Merck & Co., Inc.
• 15.7. Nestle SA
• 15.8. Zoetis Inc
• 15.9. Dechra Veterinary Products Ltd
• 15.10. Elanco Animal Health Inc

16. Strategic Recommendations

17. About Us & Disclaimer